Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

SHE:002399 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	2,176	1,422	1,766	2,139	2,944	2,712
Short-Term Investments	-	387.17	206.2	-	-	74.21
Trading Asset Securities	886.81	867.9	414.18	1,312	981.16	828.21
Cash & Short-Term Investments	3,062	2,677	2,386	3,450	3,925	3,615
Cash Growth	14.83%	12.19%	-30.85%	-12.10%	8.59%	159.98%
Accounts Receivable	1,425	1,187	1,275	1,626	1,543	1,694
Other Receivables	73.08	173.3	121.89	134.82	243.81	184.16
Receivables	1,498	1,360	1,396	1,761	1,787	1,878
Inventory	4,670	5,394	6,654	6,844	4,708	3,168
Prepaid Expenses	-	123.18	111.28	-	-	-
Other Current Assets	283.45	67.15	56.43	334.53	349.43	467.34
Total Current Assets	9,514	9,621	10,604	12,390	10,770	9,129
Property, Plant & Equipment	2,595	2,854	2,849	2,477	2,537	2,571
Long-Term Investments	986.47	1,823	2,514	2,464	2,618	3,999
Goodwill	2,347	2,357	2,322	2,351	2,152	2,203
Other Intangible Assets	371.6	301.57	370.78	522.87	546.87	615.95
Long-Term Deferred Tax Assets	317.47	282.51	320.5	141.48	121.72	83.94
Long-Term Deferred Charges	189.87	5.1	18.64	244.71	241.88	230.33
Other Long-Term Assets	913.21	98.61	203.87	224.95	120.85	194.36
Total Assets	17,235	17,344	19,203	20,816	19,108	19,026
Accounts Payable	364.79	299.69	306.34	427.43	385.79	239.22
Accrued Expenses	263.09	393.1	388	377.51	398.43	395.33
Short-Term Debt	1,801	844	1,069	2,385	1,886	1,860
Current Portion of Long-Term Debt	723.72	1,523	2,556	1,635	1,382	622.21
Current Portion of Leases	-	38.82	37.8	35.69	31.75	25.6
Current Income Taxes Payable	-	120.26	157.18	112.3	113.2	43.74
Current Unearned Revenue	209.84	264.28	362.05	433.88	383.79	265.04
Other Current Liabilities	792.51	215.92	110.24	168.2	210.34	161.93
Total Current Liabilities	4,155	3,699	4,986	5,576	4,791	3,613
Long-Term Debt	528.17	1,081	1,810	2,297	2,250	3,086
Long-Term Leases	40.83	57.77	90.42	110.75	104	51.64
Long-Term Unearned Revenue	44.54	27.29	30.43	32.55	16.67	18.74
Long-Term Deferred Tax Liabilities	226.86	242.49	252.57	328.92	275.36	427.67
Other Long-Term Liabilities	27.54	10.35	10.15	29.39	26.44	24.76
Total Liabilities	5,023	5,141	7,215	8,407	7,585	7,337
Common Stock	1,467	1,467	1,467	1,467	1,467	1,467
Additional Paid-In Capital	5,864	7,529	7,529	5,859	5,944	6,035
Retained Earnings	4,633	4,588	3,941	4,861	4,184	4,212
Comprehensive Income & Other	194.89	-1,436	-1,024	125.52	-183.36	-145.09
Total Common Equity	12,159	12,149	11,913	12,313	11,411	11,569
Minority Interest	52.76	53.45	75.23	96.72	111.96	119.6
Shareholders' Equity	12,212	12,202	11,988	12,409	11,523	11,689
Total Liabilities & Equity	17,235	17,344	19,203	20,816	19,108	19,026
Total Debt	3,094	3,545	5,563	6,464	5,654	5,645
Net Cash (Debt)	-31.36	-867.91	-3,177	-3,013	-1,729	-2,030
Net Cash Per Share	-0.02	-0.59	-2.15	-2.05	-1.18	-1.50
Filing Date Shares Outstanding	1,467	1,467	1,467	1,467	1,467	1,467
Total Common Shares Outstanding	1,467	1,467	1,467	1,467	1,467	1,467
Working Capital	5,359	5,922	5,618	6,814	5,978	5,516
Book Value Per Share	8.29	8.28	8.12	8.39	7.78	7.88
Tangible Book Value	9,440	9,490	9,220	9,439	8,712	8,751
Tangible Book Value Per Share	6.43	6.47	6.28	6.43	5.94	5.96
Land	-	34.51	34	33.43	30.61	31.32
Buildings	-	1,931	1,915	1,480	1,450	1,445
Machinery	-	2,007	1,961	1,892	1,719	1,693
Construction In Progress	-	697.77	468.72	394.53	425.35	364.39
Leasehold Improvements	-	15.73	15.43	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.